Axillary lymph node involvement in women with breast cancer: Does it depend on age?

Clinical Breast Cancer

Volumn 10, Issue 4, 2010, Pages 318-321

  Botteri, Edoardo ^a   Bagnardi, Vincenzo ^a,b   Goldhirsch, Aaron ^a   Viale, Giuseppe ^a,c   Rotmensz, Nicole ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Breast cancer screening; Ductal carcinoma; Lobular carcinoma; Prognostic factor

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGE; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; DELAYED DIAGNOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PROBABILITY; PROGNOSIS; PROTEIN EXPRESSION; TUMOR VOLUME;

EID: 77955651626     PISSN: 15268209     EISSN: None     Source Type: Journal    
DOI: 10.3816/CBC.2010.n.042     Document Type: Article

References (23)

1. Kimmick GG, Balducci L. Breast cancer and aging. Clinical interactions. Hematol Oncol Clin North Am 2000; 14:213-234
2. Gennari R, Curigliano G, Rotmensz N, et al. Breast carcinoma in elderly women: features of disease presentation, choice of local and systemic treatments compared with younger postmenopausal patients. Cancer 2004; 101:1302-1310
3. Yancik R, Wesley MN, Ries LAG, et al. Effect of age and comorbidity in postmeno-pausal breast cancer patients aged 55 years and older. JAMA 2001; 285:885-892
4. Walter LC, Covinsky KE. Cancer screening in elderly patients: a framework for individualized decision making. JAMA 2001; 285:2750-2756
5. Fisher CJ, Egan MK, Smith P, et al. Histopathology of breast cancer in relation to age. Br J Cancer 1997; 75:593-596
6. Singh R, Hellman S, Heimann R. The natural history of breast carcinoma in the elderly: implications for screening and treatment. Cancer 2004; 100:1807-1813
7. Rivadeneira DE, Simmons RM, Christos PJ, et al. Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: analysis in more than 900 patients. J Am Coll Surg 2000; 191:1-6.
8. Gill PG, Luke CG, Roder DM. Clinical and pathological factors predictive of lymph node status in women with screen-detected breast cancer. Breast 2006; 15:640-648
9. Ezzat A, Raja MA, Zwaan F, et al. The lack of age as a significant prognostic factor in non-metastatic breast cancer. Eur J Surg Oncol 1998; 24:23-27
10. Diab SG, Elledge RM, Clark GM. Tumor characteristics and clinical outcomes of elderly women with breast cancer. J Natl Cancer Inst 2000; 92:550-556
11. Wildiers H, Van Calster B, van de Poll-Franse LV, et al. Relationship between age and axillary lymph node involvement in women with breast cancer. J Clin Oncol 2009; 27:2931-2937
12. Molino A, Giovannini M, Auriemma, A., et al. Pathological, biological and clinical characteristics, and surgical management, of elderly women with breast cancer. Crit Rev Oncol Hematol 2006; 59:226-233
13. Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med 1989; 8:551-561
14. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996; 15:361-387
15. Holmes CE, Muss HB. Diagnosis and treatment of breast cancer in the elderly. CA Cancer J Clin 2003; 53:227-244
16. Mittra I, MacRae KD. A meta-analysis of reported correlations between prognostic factors in breast cancer: does axillary lymph node metastasis represent biology or chronology? Eur J Cancer 1991; 27:1574-1583
17. Smith RA, Saslow D, Sawyer KA, et al. American Cancer Society guidelines for breast cancer screening: update 2003. CA Cancer J Clin 2003; 53:141-169
18. Walter LC, Lewis CL, Barton MB. Screening for colorectal, breast, and cervical cancer in the elderly: a review of the evidence. Am J Med 2005; 118:1078-1086
19. Fabbri S, Perfetti E, Govoni D, et al. Benign breast diseases in breast cancer screening programs in Italy (2000-2001). Tumori 2004; 90:547-549
20. Jørgensen KJ, Gøtzsche PC. Overdiagnosis in publicly organised mammogra-phy screening programmes: systematic review of incidence trends. BMJ 2009; 339:b2587.
21. Zackrisson S, Andersson I, Janzon L, et al. Rate of over-diagnosis of breast cancer 15 years abate the end of the Malmo mammographic screening trial. BMJ 2006; 332:689-692
22. Evans A, Cornford E, James J. Breast screening overdiagnosis. stop treating indolent lesions. BMJ 2009; 339:b3256.
23. Veronesi U, Paganelli G, Viale G, et al. Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol 2006; 7:983-990